KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Cash & Current Investments (2016 - 2025)

Evolent Health (EVH) has 11 years of Cash & Current Investments data on record, last reported at $140.3 million in Q3 2025.

  • For Q3 2025, Cash & Current Investments rose 24.28% year-over-year to $140.3 million; the TTM value through Sep 2025 reached $140.3 million, up 24.28%, while the annual FY2024 figure was $163.5 million, 20.86% down from the prior year.
  • Cash & Current Investments reached $140.3 million in Q3 2025 per EVH's latest filing, down from $175.4 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $342.0 million in Q4 2021 and bottomed at $112.9 million in Q3 2024.
  • Average Cash & Current Investments over 5 years is $210.7 million, with a median of $206.6 million recorded in 2023.
  • Peak YoY movement for Cash & Current Investments: surged 136.59% in 2021, then crashed 45.64% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $342.0 million in 2021, then plummeted by 40.73% to $202.7 million in 2022, then rose by 1.92% to $206.6 million in 2023, then decreased by 20.86% to $163.5 million in 2024, then decreased by 14.16% to $140.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Current Investments were $140.3 million in Q3 2025, $175.4 million in Q2 2025, and $262.7 million in Q1 2025.